Ciliary neurotrophic factor-mediated neuroprotection involves enhanced glycolysis and anabolism in degenerating mouse retinas
Kun Do RheeiD, Yanjie WangiD, Johanna ten HoeveiD, Linsey StilesiD, Thao Thi Thu Nguyen, Xiangmei ZhangiD, Laurent VergnesiD, Karen ReueiD, Orian S. ShirihaiiD, Dean Bok, Xian-Jie YangiD
Abstract
Ciliary neurotrophic factor (CNTF) acts as a potent neuroprotective cytokine in multiple models of retinal degeneration. To understand mechanisms underlying its broad neuroprotective effects, we have investigated the influence of CNTF on metabolism in a mouse model of photoreceptor degeneration. CNTF treatment improves the morphology of photoreceptor mitochondria, but also leads to reduced oxygen consumption and suppressed respiratory chain activities. Molecular analyses show elevated glycolytic pathway gene transcripts and active enzymes. Metabolomics analyses detect significantly higher levels of ATP and the energy currency phosphocreatine, elevated glycolytic pathway metabolites, increased TCA cycle metabolites, lipid biosynthetic pathway intermediates, nucleotides, and amino acids. Moreover, CNTF treatment restores the key antioxidant glutathione to the wild type level. Therefore, CNTF significantly impacts the metabolic status of degenerating retinas by promoting aerobic glycolysis and augmenting anabolic activities. These findings reveal cellular mechanisms underlying enhanced neuronal viability and suggest potential therapies for treating retinal degeneration.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 46
- FWCI
- 2.53
- Field percentile
- top 8%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Retinal metabolism: Evidence for uncoupling of glycolysis and oxidative phosphorylation via Cori-, Cahill-, and mini-Krebs-cycle
Y. Chen, L. Zizmare, … C. Trautwein·bioRxiv·Jun 20, 2022
- Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
James R. Tribble, Amin Otmani, … Pete A. Williams·Redox BiologyPeer-reviewed·Apr 24, 2021
- The 5-HT1A receptor antagonist WAY-100635 maleate reprograms metabolism to promote RGC differentiation and regeneration in retino-visual centers
Sayanta Dutta, Michelle L. Surma, … Arupratan Das·Communications MedicinePeer-reviewed·Apr 2, 2026
- Glycolytic reliance promotes anabolism in photoreceptors
Y. Chinchore, T. Begaj, … C. L. Cepko·bioRxiv·Jan 21, 2017
- Continuous Hypoxia Reduces Retinal Ganglion Cell Degeneration in a Mouse Model of Mitochondrial Optic Neuropathy
A. M. Warwick, H. M. Bomze, … S. Gospe·Investigative Opthalmology & Visual SciencePeer-reviewed·Dec 20, 2022
- Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration
K. Wert, G. Velez, … V. B. Mahajan·bioRxiv·Sep 10, 2019